<?xml version="1.0" encoding="UTF-8"?>
<p>Although the medicinal use of cannabis in Europe dates back to the 13th century, it was only popularized in the 19th century when it was found to have anticonvulsive, analgesic, antianxiety and antiemetic effects [
 <xref rid="B21-antibiotics-09-00406" ref-type="bibr">21</xref>]. Over the past decade, advocates of medicinal cannabis have highlighted its potential for treating a variety of conditions, including cancer [
 <xref rid="B22-antibiotics-09-00406" ref-type="bibr">22</xref>]. This has sparked a range of reactions, from reluctance and caution [
 <xref rid="B23-antibiotics-09-00406" ref-type="bibr">23</xref>] to excitement [
 <xref rid="B24-antibiotics-09-00406" ref-type="bibr">24</xref>]. The reluctance stems from the adverse effects of cannabis, which limit its widespread therapeutic use. Cannabis use has been known to cause psychological effects for at least 4,000 years [
 <xref rid="B25-antibiotics-09-00406" ref-type="bibr">25</xref>], including symptoms such as euphoria, intensification of sensory perceptions and impaired motor skills in healthy individuals [
 <xref rid="B26-antibiotics-09-00406" ref-type="bibr">26</xref>]. Most commonly, it has well-documented deleterious effects on neurocognitive functioning in humans [
 <xref rid="B27-antibiotics-09-00406" ref-type="bibr">27</xref>]. It has also been linked to deficits in working and episodic memory [
 <xref rid="B28-antibiotics-09-00406" ref-type="bibr">28</xref>], executive functions [
 <xref rid="B29-antibiotics-09-00406" ref-type="bibr">29</xref>], anhedonia and anxiety [
 <xref rid="B30-antibiotics-09-00406" ref-type="bibr">30</xref>]. A recent report by the WHO also suggested an association between myocardial infarction or stroke with heavy cannabis use [
 <xref rid="B31-antibiotics-09-00406" ref-type="bibr">31</xref>]. The adverse effects on the cardiovascular system is most likely caused by CB
 <sub>1</sub> receptor activation by Î”
 <sup>9</sup>-THC, while CBD seems to have beneficial effects [
 <xref rid="B32-antibiotics-09-00406" ref-type="bibr">32</xref>]. Moreover, some medical professionals have concerns about prescribing medicinal cannabis (where it is legalized) due to its potential addictive properties. However, it should be acknowledged that there are disparities and contradictions in findings between studies. Regardless, healthcare practitioners should be aware of these adverse effects and inform their patients before prescription. Recently, evidence surrounding the use of cannabinoids on treatment-resistant refractory epilepsy has increased [
 <xref rid="B33-antibiotics-09-00406" ref-type="bibr">33</xref>,
 <xref rid="B34-antibiotics-09-00406" ref-type="bibr">34</xref>,
 <xref rid="B35-antibiotics-09-00406" ref-type="bibr">35</xref>]. There are also strong indications that cannabinoids are effective agents for the treatment of chronic pain, nausea post-chemotherapy and appetite stimulation [
 <xref rid="B36-antibiotics-09-00406" ref-type="bibr">36</xref>,
 <xref rid="B37-antibiotics-09-00406" ref-type="bibr">37</xref>,
 <xref rid="B38-antibiotics-09-00406" ref-type="bibr">38</xref>,
 <xref rid="B39-antibiotics-09-00406" ref-type="bibr">39</xref>,
 <xref rid="B40-antibiotics-09-00406" ref-type="bibr">40</xref>].
</p>
